"Generation are delighted to partner with SOPHiA GENETICS. We believe that leveraging genetic sequencing and advanced digital analysis will enable a more sustainable healthcare system. SOPHiA GENETICS is a leader in the preventive and personalized medicine revolution, enabling the development of targeted therapeutics, thereby vastly improving health outcomes," said Lilly Wollman, co-head of Generation's Growth Equity team. "We admire SOPHiA GENETICS not just for its differentiated analytics capability across genomic and radiomic data, but also for its exceptional team and culture."
"Since we founded the company, our goal has been to help make the global healthcare system more sustainable. By helping clinical researchers leverage their expertise and work together as a community, patients all over the world can receive equal access to better care. Generation Investment Management and SOPHiA GENETICS are guided by the same belief. With Generation's support, we will enable the more rapid adoption of Data-Driven Medicine technology in healthcare for the benefit of patients worldwide," commented Dr. Jurgi Camblong, CEO and Founder of SOPHiA GENETICS.
New Era in Electronics Tosoh s GaN Sputtering Target Could Fuel India s 5G and Data Center Expansion
Chemical Market has been in the industry since almost 40 years. We owe our success to you and since the last few years things have been crazy for the world at large. The editorial independence has never been more important.
Our articles and press releases come from reliable sources and we keep delivering high impact trustworthy news, reviews and technical articles and reports free from commercial or political influence.
We believe everyone deserves equal access to accurate news and there are many news aggregator sites but we don't participate in those as they have a very broad criteria where not all news articles sites can participate and not all of them are true articles written for the purpose of knowledge but mostly are commercialized. We bring you news and information in the chemical industry and provide vital information to make decisions based on fact and not fiction.
Subscribe our magazine for as little as Rs.50 a month (Rs. 600/yr) or $1 a month ($11.99/yr)
